27/09/2024
🚀 Happy to announce that our latest research is now published in Angewandte Chemie International Edition! 🎉
🔍 Key Highlights: Ventricular arrhythmias (VAs) from myocardial infarction (MI) are a leading cause of sudden cardiac death. With current treatments falling short, we aimed to find a better solution!
💡 Our Breakthrough: Introducing RuB—a novel supramolecular sonosensitizer that boosts pro-survival autophagy in microglia BV2 cells with ultrasound exposure.
🌟 Key Findings: RuB significantly reduces sympathetic nervous activity and inflammation, all while causing no tissue injury post-treatment.
🔮 Future Prospects: This pioneering work on long-wave emission supramolecular sonosensitizers paves the way for innovative strategies in cardiovascular disease management, extending the reach of sonodynamic therapy beyond cancer.
